Methylphenidate Hydrochloride Tablet, Chewable
Product Images NDC 72162-1306

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 72162-1306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621306)

Label for Methylphenidate Hydrochloride Chewable Tablets, USP 10 mg, containing 100 chewable tablets. The label includes the NDC 72162-1306-1 and states the product is Rx only. It is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Ascent Pharmaceuticals, Inc. Storage and safety instructions are printed, including keeping out of reach of children and storing at 20° to 25°C.*

FDA Label Image

Structure (Methylephenidate Structure)

Chemical structure of Methylphenidate Hydrochloride displayed as a molecular diagram showing its atoms and bonds including the hydrochloride component.*

FDA Label Image

Mg1 (Mg1)

Text panel containing safety and usage warnings for methylphenidate hydrochloride chewable tablets. It includes guidance about risk of abuse, misuse, addiction, physical dependence, proper storage, and the importance of healthcare provider monitoring during treatment.*

FDA Label Image

Mg2 (Mg2)

A text panel providing safety information for methylphenidate hydrochloride chewable tablets. It warns about serious heart-related risks such as sudden death, stroke, heart attack, and increased blood pressure. It advises patients or caregivers to inform healthcare providers about heart conditions and to monitor blood pressure and heart rate during treatment. Immediate medical attention is recommended if symptoms like chest pain, shortness of breath, or fainting occur.*

FDA Label Image

Mg3 (Mg3)

A text excerpt from drug safety information for methylphenidate hydrochloride chewable tablets. It discusses warnings about new or worsening mental symptoms or problems, including behavioral and thought issues, bipolar illness, aggressive behavior, psychotic symptoms, and manic symptoms in children, teenagers, and all patients. It advises contacting a healthcare provider immediately if such symptoms occur while taking the medication.*

FDA Label Image

Mg4 (Mg4)

This image shows a text panel providing safety information and warnings related to methylphenidate hydrochloride chewable tablets. It advises patients or caregivers to inform healthcare providers if there are symptoms such as numbness, pain, skin color changes, or sensitivity to temperature in fingers or toes, and to seek medical attention immediately if unexplained wounds appear on fingers or toes during treatment.*

FDA Label Image

Mg5 (Mg5)

A bullet-point list of common side effects associated with the drug, including nervousness, trouble sleeping, headache, stomach ache, fast heart beat, nausea, decreased appetite, dizziness, and weight loss.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.